Ridgemont Equity Partners, a growth equity investor, agreed to acquire American Outcomes Management, a provider of home-based intravenous immunoglobulin therapy. Financial terms were not disclosed. “AOM has a tremendous growth opportunity ahead and several avenues for expansion, Our vision for the business starts with investing in our team and capabilities to expand our presence in all geographic markets and offer additional specialty infusion therapies. Infusion services continue to shift out of the hospital setting towards alternative sites as patients, providers and payors prefer the comfort and cost-effectiveness of at-home treatment. With Ridgemont’s support, AOM can broaden its reach and help more people in our communities find long-term care solutions,” Chris York, AOM Chairman.